Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1381 studies found for:    Open Studies | "Virus Diseases"
Show Display Options
Download search resultsDownload the search results for:
Open Studies | "Virus Diseases" (1381 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Recruiting Immunogenicity, Safety and Tolerability of a Plant-Derived Seasonal Virus-Like-Particle Quadrivalent Influenza Vaccine in Adults
Conditions: Virus Diseases;   RNA Virus Infections;   Respiratory Tract Diseases;   Respiratory Tract Infections
Interventions: Biological: Low dose of quadrivalent VLP vaccine;   Biological: Medium dose of quadrivalent VLP vaccine;   Biological: High dose of quadrivalent VLP vaccine;   Biological: Placebo
2 Unknown  The Development of a Human Model of Respiratory Syncytial Virus Infection
Conditions: Respiratory Syncytial Virus Infections;   Respiratory Viral Infections
Intervention: Biological: RSV A Memphis 37
3 Recruiting Respiratory Syncytial Virus - RSV Protocol
Conditions: Bone Marrow Transplant Infection;   Infection in Marrow Transplant Recipients;   Respiratory Syncytial Virus Infections;   Respiratory Syncytial Virus Pneumonia;   Cancer;   Acute Leukemia
Intervention: Drug: Ribavirin
4 Recruiting Immunogenicity, Safety and Tolerability of a Plant-Derived Seasonal VLP Quadrivalent Influenza Vaccine in the Elderly Population
Conditions: Virus Diseases;   RNA Virus Infections;   Respiratory Tract Diseases;   Respiratory Tract Infections
Interventions: Biological: Non-adjuvanted low dose of quadrivalent VLP vaccine;   Biological: Non-adjuvanted medium dose of quadrivalent VLP vaccine;   Biological: Non-adjuvanted high dose of quadrivalent VLP vaccine;   Biological: Adjuvanted low dose of quadrivalent VLP vaccine;   Biological: Adjuvanted high dose of quadrivalent VLP vaccine;   Biological: Placebo
5 Recruiting A Study to Evaluate the Safety and Efficacy of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 Coadministered With Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection and Human Immunodeficiency Virus, Type 1 (HIV-1) Coinfection
Conditions: Hepatitis C Virus Infection;   Human Immunodeficiency Virus Infection;   Chronic Hepatitis C;   Compensated Cirrhosis and Non-cirrhotics
Interventions: Drug: ABT-450/r/ABT-267;   Drug: ABT-333;   Drug: Ribavirin (RBV)
6 Recruiting Efficacy of Favipiravir Against Ebola (JIKI)
Condition: Ebola Virus Disease
Intervention: Drug: Favipiravir
7 Recruiting Phase II of Chemotherapy for Relapsed Epstein Barr Virus Associated Lymphoma
Conditions: Epstein Barr Virus Associated Non Hodgkin's Lymphoma;   Epstein Barr Virus Associated Hodgkin's Lymphoma;   Post-Transplant Lymphoproliferative Disease
Interventions: Drug: Doxorubicin;   Drug: Methotrexate;   Drug: Leucovorin;   Biological: Hydroxyurea;   Drug: Zidovudine;   Procedure: Urine Alkalization
8 Recruiting Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of GS-9857 in Subjects With Chronic Hepatitis C Virus Infection
Condition: Hepatitis C Virus Infection
Interventions: Drug: GS-9857;   Drug: Placebo to match GS-9857
9 Recruiting Respiratory Virus Hospitalization Study (FLU 003 Plus)
Conditions: Influenza;   Novel Respiratory Virus-1 MERS-CoV;   Novel Respiratory Virus-2 SARS-CoV
Intervention:
10 Recruiting Utilization and Compliance of Respiratory Syncytial Virus Monoclonal Antibody Therapy
Conditions: Lower Respiratory Tract Infection;   Respiratory Syncytial Virus Infections
Intervention:
11 Recruiting Using Multi-virus Cytotoxic T-cells Following T-Cell Depleted Allogeneic HPCT for Prophylaxis Against Epstein Barr Virus, Adenovirus, And Cytomegalovirus
Conditions: Epstein-Barr Virus Infections;   Adenovirus;   Cytomegalovirus Infections
Intervention: Biological: Cytotoxic T Lymphocytes
12 Not yet recruiting Chronic Fatigue Following Acute Epstein-Barr Virus Infection in Adolescents
Conditions: Fatigue Syndrome, Chronic;   Epstein-Barr Virus Infections
Intervention:
13 Recruiting A Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir With Sofosbuvir With and Without Ribavirin in Adults With Chronic Hepatitis C Virus Infection
Condition: Chronic Hepatitis C Virus Infection
Interventions: Drug: Ombitasvir/ABT-450/r;   Drug: Sofosbuvir;   Drug: Ribavirin (RBV)
14 Recruiting Viral Infections in Healthy and Immunocompromised Hosts
Condition: Herpes Viruses
Intervention:
15 Recruiting GS-5806 in Hematopoietic Cell Transplant Recipients With Respiratory Syncytial Virus Infection of the Upper Respiratory Tract
Condition: Respiratory Syncytial Virus
Interventions: Drug: GS-5806;   Drug: Placebo
16 Recruiting Clinical Trial to Evaluate the Efficacy and Safety of Convalescent Plasma for Ebola Treatment
Condition: Ebola Virus Disease
Intervention: Procedure: Convalescent Plasma Treatment
17 Not yet recruiting Most Closely Human Leukocyte Antigen (HLA)-Matched BK Virus-specific T Lymphocytes (Viralym-B)
Condition: BK Virus Infection
Intervention: Biological: Viralym-B
18 Recruiting Genetic Studies of Chronic Active Epstein-Barr Disease
Condition: Epstein-Barr Virus Infections
Intervention:
19 Unknown  Biliverdin Reductase A in Chronic Hepatitis C Virus Infection
Condition: Hepatitis C Virus Infection
Intervention:
20 Recruiting A Phase Ib Trial of MVA-EBNA1/LMP2 Vaccine in Nasopharyngeal Carcinoma
Conditions: Nasopharyngeal Cancer;   Epstein Barr Virus Infections
Intervention: Drug: MVA-EBNA1/LMP2 vaccine

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years